Publicacións en colaboración con investigadores/as de Universidade da Coruña (209)

2024

  1. Addressing the data bottleneck in medical deep learning models using a human-in-the-loop machine learning approach

    Neural Computing and Applications, Vol. 36, Núm. 5, pp. 2597-2616

  2. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer

    Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8

  3. Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 88-94

  4. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial

    Progress in Cardiovascular Diseases

  5. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment

  6. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology

  7. Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma

    Molecular Oncology, Vol. 18, Núm. 5, pp. 1143-1173

  8. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis

    Molecular Oncology, Vol. 18, Núm. 5, pp. 1093-1122

  9. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

    Clinical and Translational Oncology

2023

  1. Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)

    Scientific Reports

  2. Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)

    Clinical and Translational Oncology

  3. Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer

    Scientific Reports, Vol. 13, Núm. 1

  4. Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study

    Journal of Foot and Ankle Research, Vol. 16, Núm. 1

  5. Human-in-the-Loop Machine Learning for the Treatment of Pancreatic Cancer

    Proceedings of the International Joint Conference on Neural Networks

  6. Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer

    Cancers, Vol. 15, Núm. 17

  7. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

  8. Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges

    Nature Reviews Clinical Oncology, Vol. 20, Núm. 10, pp. 664-677

  9. Locoregional relapse after sparing mastectomies and immediate reconstruction in women with breast cancer

    Cirugia Espanola, Vol. 101, Núm. 2, pp. 97-106

  10. MET alterations in NSCLC—Current Perspectives and Future Challenges

    Journal of Thoracic Oncology, Vol. 18, Núm. 4, pp. 419-435

  11. Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer (Scientific Reports, (2023), 13, 1, (15401), 10.1038/s41598-023-42037-w)

    Scientific Reports